These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17008024)

  • 1. Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain.
    Alisky JM
    Med Hypotheses; 2007; 68(2):460-1. PubMed ID: 17008024
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
    Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA
    Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
    Ryan DH
    Endocrine; 2000 Oct; 13(2):193-9. PubMed ID: 11186220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia.
    Biedermann F; Fleischhacker WW; Kemmler G; Ebenbichler CF; Lechleitner M; Hofer A
    Int Clin Psychopharmacol; 2014 May; 29(3):181-4. PubMed ID: 24300751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity.
    Arterburn D; DeLaet D; Flum D
    Clin Evid; 2005 Jun; (13):707-25. PubMed ID: 16135277
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity.
    Arterburn D
    Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
    Ferrer-Lorente R; Cabot C; Fernández-López JA; Remesar X; Alemany M
    Eur J Pharmacol; 2005 Apr; 513(3):243-8. PubMed ID: 15862807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appetite suppressants in pregnancy.
    Manakova E; Kralova T; Hubičková Heringová L
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():179-82. PubMed ID: 23353864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.
    Slovacek L; Pavlik V; Slovackova B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):e43-4. PubMed ID: 18676135
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
    Arman S; Sadramely MR; Nadi M; Koleini N
    Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
    von Haehling S; Lainscak M; Anker SD
    Eur Heart J; 2007 Dec; 28(23):2830-1. PubMed ID: 17984134
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological and surgical treatment of obesity.
    Shekelle PG; Morton SC; Maglione M; Suttorp M; Tu W; Li Z; Maggard M; Mojica WA; Shugarman L; Solomon V
    Evid Rep Technol Assess (Summ); 2004 Jul; (103):1-6. PubMed ID: 15526396
    [No Abstract]   [Full Text] [Related]  

  • 18. Sibutramine for compulsive eating in hypothalamic deficiency.
    Arango C; Rojas MJ; Moreno D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1147-8. PubMed ID: 12364836
    [No Abstract]   [Full Text] [Related]  

  • 19. Sibutramine in pregnancy.
    Ramzi F; Elias D; Mona S; Zreik TG
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):243-4. PubMed ID: 16219525
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany.
    Brennan A; Ara R; Sterz R; Matiba B; Bergemann R
    Eur J Health Econ; 2006 Dec; 7(4):276-84. PubMed ID: 17063345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.